Aerie Pharmaceuticals Inc (NASDAQ:AERI) Investor Alert: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Aerie Pharmaceuticals Inc in connection with certain allegedly false and misleading statements made between August 6, 2014 and April 23, 2015.
View full press release